Conference item icon

Conference item

Stomach dose-volume parameters and clinical factors predict acute toxicity in pancreatic cancer chemoradiotherapy

Abstract:
Gastrointestinal (GI) toxicity impedes dose escalation and likelihood of cure in chemoradiotherapy (CRT) for hepatobiliary malignancies. The risk of toxicity can depend on clinical and radiotherapy (RT) dose-volume metrics. We aimed to identify predictive factors using data from two prospective phase-II clinical trials of locally-advanced pancreatic cancer (LAPC).
Publication status:
Published
Peer review status:
Peer reviewed
Version:
Accepted manuscript

Actions


Access Document


Files:
Publisher copy:
10.1016/j.ijrobp.2017.06.971

Authors


Holyoake, DL More by this author
More by this author
Institution:
University of Oxford
Division:
Medical Sciences Division
Department:
Oncology
More by this author
Institution:
University of Oxford
Division:
Medical Sciences Division
Department:
Oncology
Subgroup:
CRUK/MRC Ox Inst Radiation Oncology
More by this author
Institution:
University of Oxford
Division:
Medical Sciences Division
Department:
Oncology
Subgroup:
CRUK/MRC Ox Inst Radiation Oncology
ORCID:
0000-0002-6669-0628
Publisher:
Elsevier Publisher's website
Volume:
99
Issue:
2
Pages:
E155
Publication date:
2017-09-23
DOI:
EISSN:
1879-355X
ISSN:
0360-3016
Pubs id:
pubs:743763
URN:
uri:3cc91fd6-b688-4a67-8f4b-d281c49aaa3f
UUID:
uuid:3cc91fd6-b688-4a67-8f4b-d281c49aaa3f
Local pid:
pubs:743763

Terms of use


Metrics



If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP